Target intelligence / Profile preview

Protein tyrosine kinase 2 beta (PTK2B)

Target
PTK2B
Molecular classification
Enzyme, Kinase, Non-receptor tyrosine kinase, Focal adhesion kinase family
01

Overview

Protein tyrosine kinase 2 beta (PTK2B), commonly known as proline-rich tyrosine kinase 2 (Pyk2), is a cytoplasmic, non-receptor tyrosine kinase belonging to the focal adhesion kinase (FAK) family. Unlike FAK, Pyk2 is highly sensitive to intracellular calcium levels and is primarily activated in response to calcium influx, membrane depolarization, and protein kinase C activation. It plays a critical role in regulating the actin cytoskeleton, cell polarization, migration, adhesion, and synaptic plasticity. PTK2B is implicated in several pathological conditions, including various cancers (such as glioblastoma, multiple myeloma, and breast cancer) where it promotes tumor cell invasion, survival, and metastasis. Additionally, PTK2B is a well-known genetic risk locus for late-onset Alzheimer's disease, contributing to amyloid-beta toxicity and tau phosphorylation. Therapeutic targeting of PTK2B is primarily pursued using small-molecule dual FAK/Pyk2 inhibitors, such as defactinib and PF-562271, which are being evaluated in clinical trials for oncology and inflammatory diseases.

Other names
Pyk2Proline-rich tyrosine kinase 2Focal adhesion kinase 2FAK2Cell adhesion kinase betaCAK-betaCAKBCalcium-dependent tyrosine kinaseCADTKRAFTK
02

Mechanism of action

ATP-competitive inhibition of tyrosine kinase activity, blocking autophosphorylation and downstream signaling pathways

03

Biological functions

Signal transductionCell migrationCell adhesionCytoskeletal reorganizationCell proliferationApoptosisSynaptic plasticityBone remodelingImmune response
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseObesity
05

Safety considerations

NauseaVomitingDiarrheaHeadacheFatigueDehydrationEdemaIncreased blood creatine phosphokinaseAnemiaOcular toxicities
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

PTK2B mRNA expressionPyk2 phosphorylation levelsFAK phosphorylation levelsKRAS mutation statusKi67 proliferation index

Beyond the preview

Go deeper on Protein tyrosine kinase 2 beta (PTK2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein tyrosine kinase 2 beta (PTK2B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call